Arkema SA (OTCMKTS:ARKAY – Get Free Report) has been assigned a consensus rating of “Reduce” from the eight analysts that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating on the company.
A number of equities analysts recently weighed in on ARKAY shares. Berenberg Bank lowered shares of Arkema from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. The Goldman Sachs Group downgraded shares of Arkema from a “buy” rating to a “neutral” rating in a report on Monday, June 8th. Kepler Capital Markets cut shares of Arkema from a “hold” rating to a “strong sell” rating in a research note on Thursday, May 7th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Arkema in a report on Tuesday, June 23rd. Finally, Zacks Research upgraded Arkema from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th.
View Our Latest Stock Analysis on Arkema
Arkema Stock Down 0.5%
Arkema (OTCMKTS:ARKAY – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.10. The business had revenue of $2.57 billion during the quarter, compared to analyst estimates of $2.52 billion. Arkema had a net margin of 0.46% and a return on equity of 4.06%. Research analysts predict that Arkema will post 3.48 EPS for the current fiscal year.
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Featured Stories
- Five stocks we like better than Arkema
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
